Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureSight is an Israeli medical device company focused on developing advanced ophthalmic solutions, specifically a novel intraocular lens (IOL) for the treatment of presbyopia. The company's core technology utilizes a unique optical design to provide an extended depth of focus (EDOF), allowing patients to see clearly at various distances without the common side effects of multifocal lenses, such as halos or glare. By integrating sophisticated wavefront-shaping optics into a standard IOL format, PureSight aims to restore youthful vision to aging patients undergoing cataract surgery or refractive lens exchange. The company is currently advancing its lead product through clinical validation to establish safety and efficacy in human subjects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PureSight.